![Constantine E. Anagnostopoulos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Constantine E. Anagnostopoulos
Direttore/Membro del Consiglio presso ActivBiotics, Inc.
Profilo
Constantine E.
Anagnostopoulos is currently a Director at ActivBiotics, Inc. He was previously the Chairman at Deltagen, Inc. and Kereos, Inc. He also served as a Director at Dyax Corp.
and Genzyme Corp.
Additionally, he was a Director at ZyStor Therapeutics, Inc. and a Principal at Monsanto Co. Anagnostopoulos holds a doctorate degree from Harvard University.
Posizioni attive di Constantine E. Anagnostopoulos
Società | Posizione | Inizio |
---|---|---|
ActivBiotics, Inc.
![]() ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Constantine E. Anagnostopoulos
Società | Posizione | Fine |
---|---|---|
DYAX CORP. | Direttore/Membro del Consiglio | 16/02/2011 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/01/2005 |
DELTAGEN INC. | Presidente | - |
MONSANTO | Corporate Officer/Principal | - |
ZyStor Therapeutics, Inc.
![]() ZyStor Therapeutics, Inc. Medical SpecialtiesHealth Technology ZyStor Therapeutics, Inc. develops innovative therapeutics. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was founded by Brian L. Clevinger, James S. Manuso and Allan R. Goldberg and is headquartered in Milwaukee, WI. | Direttore/Membro del Consiglio | - |
Formazione di Constantine E. Anagnostopoulos
Harvard University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
DELTAGEN INC. | Commercial Services |
Aziende private | 6 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Dyax Corp.
![]() Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
ActivBiotics, Inc.
![]() ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Health Technology |
Kereos, Inc.
![]() Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Health Technology |
ZyStor Therapeutics, Inc.
![]() ZyStor Therapeutics, Inc. Medical SpecialtiesHealth Technology ZyStor Therapeutics, Inc. develops innovative therapeutics. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was founded by Brian L. Clevinger, James S. Manuso and Allan R. Goldberg and is headquartered in Milwaukee, WI. | Health Technology |
Monsanto Co.
![]() Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
- Borsa valori
- Insiders
- Constantine E. Anagnostopoulos